Tatiana Baker of Boynton Beach, Florida was diagnosed with advanced kidney cancer in the summer of 2014. After running out of treatment options in just a few months, she traveled to MedStar Georgetown where she enrolled in the IMmotion 150 study, a phase II clinical trial of the immunotherapy atezolizumab through Georgetown University’s Lombardi Comprehensive Cancer Center. Atezolizumab was approved for bladder cancer in May 2016. Watch to see how Tatiana became cancer free. For more information call 1-888-666-3432 or go to [ Ссылка ]
